Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

World journal of gastroenterology

Volumn 20, Issue 48, 2014, Pages 18228-18239

  Gonçalves, Fabiany da Costa ^a   Schneider, Natália ^a   Pinto, Fernanda O tesbelgue ^a   Meyer, Fabíola Schons ^a   Visioli, Fernanda ^a   Pfaffenseller, Bianca ^a   Lopez, Patrícia Luciana da Costa ^a   Passos, Eduardo P andolfi ^a   Cirne Lima, Elizabeth O bino ^a   Meurer, Luíse ^a   Paz, Ana H elena ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Cell transplantation; Dextran sulfate sodium; Immunomodulation; Inflammatory bowel disease; Intravenous injection; Mesenchymal stem cell; Ulcerative colitis

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CYTOKINE; DEXTRAN SULFATE;

ACUTE DISEASE; ANIMAL; APOPTOSIS; BLOOD; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; COLITIS; COLON; COMPARATIVE STUDY; DISEASE MODEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PARENTERAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; REGENERATION; T LYMPHOCYTE; TIME FACTOR;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BIOMARKERS; CELLS, CULTURED; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; PHENOTYPE; REGENERATION; T-LYMPHOCYTES; TIME FACTORS;

EID: 84924424942     PISSN: None     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i48.18228     Document Type: Article

References (0)